500mg Brevital Sodium (Methohexital)

Product Description: Brevital Sodium 500mg (Methohexital)

What is Brevital Sodium 500mg (Methohexital)?

Brevital Sodium 500mg (Methohexital) is a prescription barbiturate anesthetic supplied as methohexital sodium for injection. It is a rapid, ultrashort-acting anesthetic used in controlled medical settings where anesthesia or deep sedation is required. Because methohexital can significantly affect breathing, blood pressure, heart function, and consciousness, Brevital Sodium should be administered only by appropriately trained healthcare professionals, with continuous patient monitoring and immediate access to airway-management and resuscitation equipment.

Active Ingredients: Brevital Sodium contains methohexital sodium. Each vial contains 500 mg of methohexital sodium. According to the current U.S. product labeling, the formulation also contains sodium carbonate as a buffer, with sodium hydroxide used for pH adjustment. Methohexital belongs to the barbiturate class of medicines and produces rapid central nervous system depression to induce anesthesia.

Structural Formula of Methohexital Sodium

Indications: Brevital Sodium 500mg may be used in adults for intravenous induction of anesthesia before administering other general anesthetic agents. It can also be used during short surgical, diagnostic, or therapeutic procedures involving minimal painful stimulation and as an adjunct to other anesthetic medicines in appropriate procedures. The approved uses and routes differ for pediatric patients, so administration must follow the official prescribing information and the healthcare professional’s clinical judgment.

Dosage: Brevital Sodium 500mg dosing is highly individualized. The appropriate dose depends on factors such as the patient’s age, body weight, physical condition, other medicines being administered, the procedure being performed, and the required depth and duration of anesthesia. Do not self-administer it or use it according to a general consumer dosing schedule. Healthcare professionals experienced with barbiturate anesthetics should handle preparation, dilution, dose calculation, route of administration, and monitoring.

Contraindications: Brevital Sodium is contraindicated in patients with known hypersensitivity to barbiturates and in patients with latent or manifest porphyria. It should also not be used when general anesthesia itself is contraindicated. A healthcare professional should review the patient’s medical history and current medications before administering methohexital.

Side Effects: Methohexital can cause significant respiratory and cardiovascular effects. Reported reactions include respiratory depression, temporary changes in blood pressure and heart rate, coughing, hiccups, muscle twitching, nausea, vomiting, and post-anesthetic shivering. Serious complications can include airway obstruction, laryngospasm, circulatory depression, or cardiorespiratory arrest. Allergic reactions can also occur. Patients undergoing anesthesia therefore require appropriate respiratory and cardiac monitoring throughout the procedure and recovery period.

Precautions: Extra caution may be required in patients with asthma, obstructive pulmonary disease, severe hypertension or hypotension, myocardial disease, congestive heart failure, severe anemia, or extreme obesity. Careful assessment is also recommended for debilitated patients and those with impaired respiratory, circulatory, kidney, liver, or endocrine function. Methohexital should be used with particular caution in patients with status asthmaticus.

Drug and Medical History Considerations: Before administering Brevital Sodium, healthcare professionals should be informed about the patient’s prescription medicines, nonprescription medicines, supplements, allergies, previous reactions to anesthetics, and relevant medical conditions. Other central nervous system depressants may influence the depth or duration of sedation and anesthesia, making professional medication review important before the procedure.

Storage Instructions: Store Brevital Sodium according to the conditions stated on the product packaging and official prescribing information. The current U.S. BREVITAL label specifies controlled room-temperature storage between 20°C and 25°C (68°F to 77°F). Healthcare facilities should also follow appropriate procedures for preparing, handling, and disposing of injectable medicines.

Manufacturer Information: The current U.S. BREVITAL Sodium 500 mg product label identifies Par Health USA, LLC as the labeler and lists the product as a 500 mg vial of methohexital sodium for injection. Always verify manufacturer and packaging information on the specific vial and carton supplied, as labeling and suppliers can change.

Warnings: Brevital Sodium 500mg is a potent anesthetic and can suppress respiratory function. Use only in a hospital or ambulatory care environment equipped for continuous respiratory and cardiac monitoring. Appropriate ventilation and intubation equipment, resuscitative medicines, and personnel skilled in airway management must be immediately available. For deeply sedated patients, an appropriately designated individual must provide continuous monitoring.

Direction of Use: Qualified healthcare professionals must prepare and administer Brevital Sodium in accordance with the prescribing information and the requirements of the individual procedure. The route, concentration, and amount administered vary by clinical situation. Patients should not attempt to prepare, inject, or otherwise administer methohexital themselves.

After Administration: Because anesthetic medicines may temporarily impair alertness, coordination, judgment, and reaction time, patients should follow the discharge and recovery instructions provided by their healthcare team. Activities such as driving, operating machinery, drinking alcohol, or taking other sedating substances should only be resumed when the treating healthcare professional considers it appropriate.

Conclusion: Brevital Sodium 500mg (Methohexital) is a rapid, ultrashort-acting prescription barbiturate anesthetic intended for carefully controlled medical use. Its rapid anesthetic action makes it useful for anesthesia induction and selected short procedures, but its effects on breathing, circulation, and consciousness require professional administration and continuous monitoring. Evaluate the patient’s medical history, concurrent medications, procedure requirements, and individual clinical condition before use.